GEN. DIAG. CHROMOSTRATE ANTITHROMBIN III ASSAY— 510(k) K850412

Name: FDA 510(k) clearance K850412
Creator: U.S. Food and Drug Administration
Published: 1985-05-08

Substantially Equivalent

Warner-Lambert Co.

FDA 510(k) clearance K850412 for GEN. DIAG. CHROMOSTRATE ANTITHROMBIN III ASSAY, Substantially Equivalent on 1985-05-08. Applicant: Warner-Lambert Co.. Device class: 2.

Clearance details

Applicant: Warner-Lambert Co.
Product code: Code JBQ
Device class: Class 2
Regulation: 21 CFR 864.7060
Advisory panel: Hematology
Date received: 1985-02-04
Decision date: 1985-05-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Morris Plains, NJ, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JBQ

view all

K242952 — INNOVANCE Antithrombin2025-03-28
K081769 — INNOVANCE ANTITHROMBIN WITH MODELS OPFH03, OPFHO52009-05-28
K070301 — HEMOSIL ANTITHROMBIN2007-02-23
K062431 — HEMOSIL LIQUID ANTITHROMBIN2006-09-01
K043007 — BIOPHEN ANTITHROMBIN 2.5, REFERENCE # 221102; BIOPHEN ANTITHROMBIN 5, REFERENCE # 2211052005-11-07

More clearances from Warner-Lambert Co.

view all

K024160 — NEOSPORIN SCAR SOLUTION2003-03-17
K893452 — EXTRA STRENGTH EFFERGRIP DENTURE ADHESIVE CREAM1989-06-22
K870584 — O.P.T.(TM) OVULATION PREDICTION TEST1987-11-25
K861510 — MULTILUMEN VIAPIC CENTRAL LINE CATHETER1986-06-09
K852689 — GENERAL DIAGNOSTICS CEFTAZIDIME 30 MCG SUSC DISK1985-08-19

Data sourced from openFDA. This site is unofficial and independent of the FDA.